KMT2A and neoplasm: At day 3, the fraction of neoplastic cells within the tumor masses was significantly lower in MLL-tumors (40 +/- 1.6%, n = 5) compared to AT1-tumors (67 +/- 7.5%, n = 5, p<0.05) with mostly infiltrating inflammatory cells constituting the remaining part.